Chia-Jung Tsai

Dr. Chia-Jung Tsai

I-Shou University, Kaohsiung City, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JLJUN XIAN LI
JUN XIAN LI
FXFeng-Ji Xie
Feng-Ji Xie
CCChia-Hui Chen
Chia-Hui Chen
KCKuan-Ming Chen
Kuan-Ming Chen
CTChia-Jung Tsai
Chia-Jung Tsai
Differentiating tumor tissue from dense breast tissue can be difficult. Dual-energy CT (DECT) could be suitable for making diagnoses at breast cancer follow-ups. This study investigated the contrast in DECT images and iodine maps for patients with breast cancer being followed-up. Chest CT images captured in 2019 were collected. Five cases of metastatic breast cancer in the lungs were analyzed; the contrast-to-noise ratio (for breast tissue and muscle: CNRb and CNRm, respectively), tumor-to-breast mammary gland ratio (T/B), and tumor-to-muscle ratio (T/M) were calculated. For 84 cases of no metastasis, monochromatic spectral and iodine maps were obtained to compare differences under various breast densities using the K-means algorithm. The optimal T/B, T/M, and CNRb (related to mammary glands) were achieved for the 40-keV image. Conversely, CNRm (related to lungs) was better for higher energy. The optimal balance was achieved at 80 keV. T/B, T/M, and CNR were excellent for iodine maps, particularly for density > 25%. In conclusion, energy of 80 keV is the parameter most suitable for observing the breast and lungs simultaneously by using monochromatic spectral images. Adding iodine mapping can be appropriate when a patient’s breast density is greater than 25%.

11 July 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
CCChia-hsien Chien
Chia-hsien Chien
CCChia-Ling Chiang
Chia-Ling Chiang
HLHuei-Lung Liang
Huei-Lung Liang
JHJer-Shyung Huang
Jer-Shyung Huang
CTChia-Jung Tsai
Chia-Jung Tsai
Background: Liver cancer is a major health concern worldwide. Radiofrequency ablation is a safe treatment option that can be guided by either ultrasound, computer tomography (CT), or fluoroscopy. Although ultrasound-guided radiofrequency ablation is commonly used in clinical practice, radiofrequency ablation guided by CT is more precise but requires more time and does not offer real-time monitoring, which may result in complications such as pneumothorax or organ damage. Objectives: In this study, we investigated the effect of ultrasound, CT, and combined ultrasound/CT guidance on patient survival and complication development. Methods: A total of 982 radiofrequency ablation sessions conducted on 553 patients were analyzed. Clinical outcomes were assessed during follow-up to determine the survival and recurrence rates of malignant tumors. Results: Overall, the three guidance approaches exhibited significant differences in terms of tumor size, number, complication development, and treatment duration. However, no significant differences were observed in survival rate. A comparison of the effect of CT guidance and ultrasound guidance on complication development revealed a higher odds ratio for CT guidance in some cases. A comparison of combined ultrasound/CT guidance and ultrasound guidance revealed nonsignificant differences in complication development. A comparison of CT guidance and combined ultrasound/CT guidance revealed a higher odds ratio for CT guidance in some cases. Radiofrequency ablation is a safe and effective treatment for liver tumors. However, CT has an increased incidence of complications. Conclusions: Combined ultrasound/computer tomography guidance is recommended for patients with multiple or large tumors or tumors near the hepatic dome or diaphragm.

20 May 2019 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
KLKun‐Mu Lu
Kun‐Mu Lu
DYDa‐Ming Yeh
Da‐Ming Yeh
BCBi‐Hui Cao
Bi‐Hui Cao
CLChia‐Yi Lin
Chia‐Yi Lin
CLChih‐Yu Liang
Chih‐Yu Liang
CTChia-Jung Tsai
Chia-Jung Tsai
Purpose: Although breast density is considered a strong risk factor of breast cancer, its quantitative assessment is difficult. To investigate a quantitative method of measuring breast density using dual‐energy mammographic imaging with central digital breast tomosynthesis in physically uniform and nonuniform phantoms.Material and methods: The dual‐energy imaging unit used a tungsten anode and silver filter with 30 kVp for high‐energy images and 20 kVp for low‐energy images. Uniform glandular‐equivalent phantoms were used to calibrate a dual‐energy based decomposition algorithm. The first study used uniform breast phantoms which ranged in thicknesses from 20 to 70 mm, in 10‐mm increments, and which provided 30%, 50%, and 70% of breast density. The second study used uniform phantoms ranging from 10% to 90% of breast density. The third study used non‐uniform phantoms (at an average density of 50%) with a thickness which ranged from 20 to 90 mm, in 10‐mm increments.Results: The root mean square error of breast density measurements was 2.64–3.34% for the uniform, variable thickness phantoms, 4.17% for the uniform, variable density phantoms, and 4.49% for the nonuniform, variable thickness phantoms.Conclusion: The dual‐energy technique could be used to measure breast density with a margin of error of < 10% using digital breast tomosynthesis.